Fluorescence spectroscopy for in vivo characterization of ovarian tissue

Molly Brewer, Urs Utzinger, Elvio Silva, David Gershenson, Robert C. Bast, Michele Follen, Rebecca Richards-Kortum

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background and Objective: The objective of this study was to explore whether fluorescence spectroscopy signatures differed between normal variations within the ovary, benign neoplasms, and ovarian cancer. Study Design/Materials and Methods: Ovarian tissue fluorescence emission spectra were collected sequentially at 18 excitation wavelengths ranging from 330 to 500 nm from 11 patients undergoing oophorectomy and assembled into fluorescence excitation emission matrices (EEMs); biopsies corresponded to the area interrogated. Spectral areas that could differentiate normal ovary, benign neoplasms, and cancers were evaluated, using histopathology as the reference standard. Results: The most promising measurements are (1) the integrated fluorescence intensity from 400 to 430 nm excitation at 460 nm emission, and (2) the ratios of fluorescence intensities at 330 nm excitation, 385 and 500 nm emission, and at 375 and 415 nm excitation, 460 nm emission. Simple systems to visualize these optical signatures at laparoscopy could be designed. Conclusion: Fluorescence spectroscopy may have the ability to distinguish ovarian cancers from normal ovarian structures and benign neoplasms, as well as differentiate between normal variations and metaplastic structures and should be further explored as a device for the early detection of ovarian cancers.

Original languageEnglish (US)
Pages (from-to)128-135
Number of pages8
JournalLasers in Surgery and Medicine
Volume29
Issue number2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Fluorescence Spectrometry
Ovarian Neoplasms
Fluorescence
Neoplasms
Ovariectomy
Early Detection of Cancer
Laparoscopy
Biopsy
Equipment and Supplies

Keywords

  • Fluorescence spectroscopy
  • Ovarian cancer detection

ASJC Scopus subject areas

  • Surgery

Cite this

Brewer, M., Utzinger, U., Silva, E., Gershenson, D., Bast, R. C., Follen, M., & Richards-Kortum, R. (2001). Fluorescence spectroscopy for in vivo characterization of ovarian tissue. Lasers in Surgery and Medicine, 29(2), 128-135. https://doi.org/10.1002/lsm.1098

Fluorescence spectroscopy for in vivo characterization of ovarian tissue. / Brewer, Molly; Utzinger, Urs; Silva, Elvio; Gershenson, David; Bast, Robert C.; Follen, Michele; Richards-Kortum, Rebecca.

In: Lasers in Surgery and Medicine, Vol. 29, No. 2, 2001, p. 128-135.

Research output: Contribution to journalArticle

Brewer, M, Utzinger, U, Silva, E, Gershenson, D, Bast, RC, Follen, M & Richards-Kortum, R 2001, 'Fluorescence spectroscopy for in vivo characterization of ovarian tissue', Lasers in Surgery and Medicine, vol. 29, no. 2, pp. 128-135. https://doi.org/10.1002/lsm.1098
Brewer, Molly ; Utzinger, Urs ; Silva, Elvio ; Gershenson, David ; Bast, Robert C. ; Follen, Michele ; Richards-Kortum, Rebecca. / Fluorescence spectroscopy for in vivo characterization of ovarian tissue. In: Lasers in Surgery and Medicine. 2001 ; Vol. 29, No. 2. pp. 128-135.
@article{5eeead1df768402f81219d1688df3387,
title = "Fluorescence spectroscopy for in vivo characterization of ovarian tissue",
abstract = "Background and Objective: The objective of this study was to explore whether fluorescence spectroscopy signatures differed between normal variations within the ovary, benign neoplasms, and ovarian cancer. Study Design/Materials and Methods: Ovarian tissue fluorescence emission spectra were collected sequentially at 18 excitation wavelengths ranging from 330 to 500 nm from 11 patients undergoing oophorectomy and assembled into fluorescence excitation emission matrices (EEMs); biopsies corresponded to the area interrogated. Spectral areas that could differentiate normal ovary, benign neoplasms, and cancers were evaluated, using histopathology as the reference standard. Results: The most promising measurements are (1) the integrated fluorescence intensity from 400 to 430 nm excitation at 460 nm emission, and (2) the ratios of fluorescence intensities at 330 nm excitation, 385 and 500 nm emission, and at 375 and 415 nm excitation, 460 nm emission. Simple systems to visualize these optical signatures at laparoscopy could be designed. Conclusion: Fluorescence spectroscopy may have the ability to distinguish ovarian cancers from normal ovarian structures and benign neoplasms, as well as differentiate between normal variations and metaplastic structures and should be further explored as a device for the early detection of ovarian cancers.",
keywords = "Fluorescence spectroscopy, Ovarian cancer detection",
author = "Molly Brewer and Urs Utzinger and Elvio Silva and David Gershenson and Bast, {Robert C.} and Michele Follen and Rebecca Richards-Kortum",
year = "2001",
doi = "10.1002/lsm.1098",
language = "English (US)",
volume = "29",
pages = "128--135",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Fluorescence spectroscopy for in vivo characterization of ovarian tissue

AU - Brewer, Molly

AU - Utzinger, Urs

AU - Silva, Elvio

AU - Gershenson, David

AU - Bast, Robert C.

AU - Follen, Michele

AU - Richards-Kortum, Rebecca

PY - 2001

Y1 - 2001

N2 - Background and Objective: The objective of this study was to explore whether fluorescence spectroscopy signatures differed between normal variations within the ovary, benign neoplasms, and ovarian cancer. Study Design/Materials and Methods: Ovarian tissue fluorescence emission spectra were collected sequentially at 18 excitation wavelengths ranging from 330 to 500 nm from 11 patients undergoing oophorectomy and assembled into fluorescence excitation emission matrices (EEMs); biopsies corresponded to the area interrogated. Spectral areas that could differentiate normal ovary, benign neoplasms, and cancers were evaluated, using histopathology as the reference standard. Results: The most promising measurements are (1) the integrated fluorescence intensity from 400 to 430 nm excitation at 460 nm emission, and (2) the ratios of fluorescence intensities at 330 nm excitation, 385 and 500 nm emission, and at 375 and 415 nm excitation, 460 nm emission. Simple systems to visualize these optical signatures at laparoscopy could be designed. Conclusion: Fluorescence spectroscopy may have the ability to distinguish ovarian cancers from normal ovarian structures and benign neoplasms, as well as differentiate between normal variations and metaplastic structures and should be further explored as a device for the early detection of ovarian cancers.

AB - Background and Objective: The objective of this study was to explore whether fluorescence spectroscopy signatures differed between normal variations within the ovary, benign neoplasms, and ovarian cancer. Study Design/Materials and Methods: Ovarian tissue fluorescence emission spectra were collected sequentially at 18 excitation wavelengths ranging from 330 to 500 nm from 11 patients undergoing oophorectomy and assembled into fluorescence excitation emission matrices (EEMs); biopsies corresponded to the area interrogated. Spectral areas that could differentiate normal ovary, benign neoplasms, and cancers were evaluated, using histopathology as the reference standard. Results: The most promising measurements are (1) the integrated fluorescence intensity from 400 to 430 nm excitation at 460 nm emission, and (2) the ratios of fluorescence intensities at 330 nm excitation, 385 and 500 nm emission, and at 375 and 415 nm excitation, 460 nm emission. Simple systems to visualize these optical signatures at laparoscopy could be designed. Conclusion: Fluorescence spectroscopy may have the ability to distinguish ovarian cancers from normal ovarian structures and benign neoplasms, as well as differentiate between normal variations and metaplastic structures and should be further explored as a device for the early detection of ovarian cancers.

KW - Fluorescence spectroscopy

KW - Ovarian cancer detection

UR - http://www.scopus.com/inward/record.url?scp=0034862445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034862445&partnerID=8YFLogxK

U2 - 10.1002/lsm.1098

DO - 10.1002/lsm.1098

M3 - Article

C2 - 11553899

AN - SCOPUS:0034862445

VL - 29

SP - 128

EP - 135

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 2

ER -